Ichnos Glenmark Innovation appoints Mariana Cota Stirner as chief medical officer
read at STAT ↗Neutral
Ichnos Glenmark Innovation announced the appointment of a new chief medical officer.
Mariana Cota Stirner will assume the role, bringing experience from her recent position as fractional chief medical officer and head of clinical development at Azalea Therapeutics.
Prior to that, she served as vice president and therapeutic area head of hematology at AbbVie, overseeing the company's hematology portfolio.
The hire underscores Ichnos Glenmark Innovation's effort to strengthen its clinical leadership as it advances its pipeline.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Up and down the ladder: The latest comings and goings”
read at STAT ↗481 words · retrieved Jul 17
comments(0)
5-min edit window · permanent after that